EMA headquarters in Amsterdam, in a file photo. EFE / EPA / REMKO DE WAAL SUMMARY PHOTOS OF THE YEAR OF EPA 2020 DECEMBER
The European Medicines Agency (EMA) approved this Thursday Pfizer’s vaccine against the coronavirus for children between 5 and 11 years old, although with a lower dose than that used in those over 12 years old.
With the approval of the European regulator, the continent thus joins the United States, which recently authorized the vaccine for this age group.
According to data published by the US Food and Drug Administration (FDA), the vaccine was 90.7 percent effective in preventing COVID-19 in this age group.
The injection will be administered in two doses, with an interval of three weeks between the first and the second, the agency stressed in a statement, in which it notes that the benefits of vaccinating children in that age group with Pfizer outweigh the risks. .
The most common side effects found in clinical trials were similar to those in those 12 years of age and older, including tiredness, muscle and headache pain, chills, soreness, and redness at the injection site.
The EMA’s decision comes amid a large increase in COVID-19 cases across Europe, mainly due to poor vaccination coverage in some countries and because the group of children under 11 years of age has not yet been able to receive the inoculant.
News in development …